News room

Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment

Egetis to participate at upcoming investor conferences

August 23, 2022

Stockholm, Sweden, August 23, 2022. Egetis Therapeutics AB (publ) (Nasdaq Stockholm: EGTX) today announced that the Company will participate at the following upcoming investor conferences and events:
Erik Penser Bank Bolagsdag
August 24, 2022
Handelsbanken Annual Healthcare Conference
August 24, 2022
Redeye Late-Stage Life Science Day
August 31, 2022
Pareto Annual Healthcare Conference
September 7, 2022
Egetis’ Capital Markets Day
October 13, 2022



Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10